Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
Illexcor is developing a first-in-class oral drug that directly targets the root cause of SCD
The European regulator will conduct a re-inspection of the facility to verify the compliance
The MDR certification reafirms that these products meet the highest safety, quality, and regulatory standards
Havix was incorporated under the laws of the State of Delaware on February 17, 2015
Announces Rs. 317 crore investment in new recycling plant
The new lenders – JP Morgan, HSBC, and Barclays provided fresh funding
This MoU marks a significant milestone in interdisciplinary research, paving the way for scientific advancements in homoeopathy
Encourages working women to practice self-care
Overall investment in the US facility is estimated around US$50 million
Subscribe To Our Newsletter & Stay Updated
